Back to company

ZYMENEX ApS: Financial statements 2018

CVR: 27394752

ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. That is a decrease of 72.8% compared with the year before. The profit margin was 12%. Equity amounted to DKK 82,550,000. The solvency ratio was 51.6%.

Revenue
10,758,000 kr.
Gross Profit
10,758,000 kr.
Profit/Loss
1,292,000 kr.
Equity
82,550,000 kr.
Total Assets
160,123,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201810.8 mio.10.8 mio.1.3 mio.82.5 mio.-
201739.6 mio.39.6 mio.3.4 mio.80.9 mio.-
201649.1 mio.49.1 mio.294.4 mio.230.3 mio.-
2015--52.5 mio.656 t.-64.1 mio.-
2014--67.9 mio.1.1 mio.-64.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ZYMENEX ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

ZYMENEX ApS: The 2017 annual report is outApr 19, 2018

ZYMENEX ApS has published its annual report for 2017. Revenue came to DKK 39,575,000, and the net result was DKK 3,404,000.

About ZYMENEX ApS

ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.

Other financial years